N/A UNCHANGED Last Price Updated: Add to My Watchlist
Press releases about St. Jude Medical
Abbott Announces Results of Early Tenders and Consents in Exchange Offers and Execution of Supplemental Indenture
March 07, 2017
Abbott (NYSE: ABT) announced today that, as of 5:00 p.m. New York City time, on March 6, 2017, the aggregate principal amounts of each series of notes listed in the table below issued by St. Jude...
IDEXX Laboratories Set to Join the S&P 500; Chemours to Join S&P MidCap 400; Shake Shack to Join S&P SmallCap 600
January 03, 2017
S&P MidCap 400 constituent IDEXX Laboratories, Inc. (NASD: IDXX) will replace St. Jude Medical, Inc. (NYSE: STJ) in the S&P 500, S&P SmallCap 600 constituent The Chemours Company (NYSE: CC) will...
Blog Coverage Abbott and St. Jude Medical Merger Gets OK from US and China's Anti-Trust Regulators
January 03, 2017
Medical Equipment Stocks on Investors' Radar -- Hologic, St. Jude Medical, Edwards Lifesciences, and Zimmer Biomet
December 29, 2016
St. Jude Medical Announces FDA Clearance of EnSite Precision Cardiac Mapping System
December 15, 2016
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced FDA clearance of its EnSite Precision™ cardiac mapping system and Advisor™ FL Circular Mapping Catheter, Sensor...
St. Jude Medical Announces Fourth Quarter Dividend
December 09, 2016
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its Board of Directors declared a fourth quarter dividend of $0.31 per common share of the Company’s stock. This...
St. Jude Medical Receives CE Mark Approval for Full Body MR Conditional Labeling for the Proclaim Elite Spinal Cord Stimulation System
December 08, 2016
With CE Mark approval, patients who receive the Proclaim Elite SCS system can now undergo full-body magnetic resonance imaging (MRI) diagnostic scans within approved parameters.
Deadline Upcoming in $39.25 Million Settlement in the St Jude Medical Inc (NYSE:STJ) Investor Lawsuit
November 17, 2016
San Diego, CA -- (SBWIRE) -- 11/17/2016 -- The Shareholders Foundation announced that a deadline is coming up on December 8, 2016 in the settlement reached in the securities class action lawsuit filed...
St. Jude Medical HeartMate 3 LVAS Demonstrated Improved Clinical Outcomes for Patients Suffering from Advanced Heart Failure
November 16, 2016
The MOMENTUM 3 study met its primary endpoint showing an 86.2 percent survival rate with freedom from disabling stroke and reoperation to repair or replace the HeartMate 3 LVAS.
St. Jude Medical Announces Full-Body MRI Compatibility and Second Major Upgrade for Proclaim Elite Spinal Cord Stimulation System
November 14, 2016
St. Jude Medical today announced FDA approval for full-body magnetic resonance (MR) Conditional labeling for the Proclaim Elite Spinal Cord Stimulation System.
Medical Equipment Stocks on Investors' Radar -- St. Jude Medical, Edwards Lifesciences, Zimmer Biomet, and Stryker
November 08, 2016
St. Jude Medical Gains CE Mark Approval for MRI Labeling of its Quadra Allure MP Cardiac Resynchronization Therapy Pacemaker
November 07, 2016
St. Jude Medical received CE Mark approval for its Quadra Allure MP™ cardiac resynchronization therapy pacemaker (CRT-P) with MRI labeling to allow patients full-body MRI scans if needed.
Largest Observational Study to Date of the St. Jude Medical AMPLATZER Amulet Left Atrial Appendage Occluder Demonstrates High Implant Success and Strong Safety Profile
November 02, 2016
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today presented favorable results from the largest observational study to date of the company’s AMPLATZER™ Amulet™ left atrial...
St. Jude Medical Welcomes Landmark Stroke Data from the RESPECT Trial
November 01, 2016
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the long-term data from RESPECT, a landmark trial, during a First Report session at the 2016 Transcatheter...
ILUMIEN III Clinical Trial Results from St. Jude Medical Demonstrate Important Findings with Advanced Intravascular Imaging Technology
October 30, 2016
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the ILUMIEN III trial met its primary endpoint demonstrating percutaneous coronary intervention (PCI) guided by...
St. Jude Medical Announces FDA Approval and U.S. Launch of the First and Only Medical Device Indicated to Reduce the Risk of Recurrent Ischemic Stroke in Patients with a PFO
October 28, 2016
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the U.S. Food and Drug Administration (FDA) approval and launch of the AMPLATZER™ PFO Occluder to help reduce the...
St. Jude Medical Shareholders Approve Merger with Abbott
October 26, 2016
St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today announced that, based on the preliminary voting results from St. Jude Medical’s Annual Meeting of Shareholders held earlier...
St. Jude Medical Announces Data to be Presented as Late-Breaking Clinical Trials and Highlights Its Latest Cardiovascular Portfolio at the 2016 TCT Conference
October 24, 2016
St. Jude Medical TCT data presentations and multiple product releases demonstrate company's commitment to transforming the treatment of cardiovascular disease
St. Jude Medical Reports Third Quarter 2016 Results
October 19, 2016
St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today reported sales and net earnings for the third quarter ended October 1, 2016.
St. Jude Medical, FDA and Top Pediatric Cardiology Experts Announce New Clinical Trial to Treat Congenital Heart Defects
October 18, 2016
Within a new U.S. clinical trial, St. Jude Medical is helping physicians evaluate a minimally invasive device as alternative to open heart surgery for babies—including premature newborns.
St. Jude Medical and Abbott to Sell Portion of Vascular Closure and Electrophysiology Businesses to Terumo Corporation
October 18, 2016
St. Jude Medical announced that it is forming a Cyber Security Medical Advisory Board to advise the company as it advances cyber security standards in the device industry.
Investigation for Investors in Shares of St. Jude Medical, Inc. (NYSE:STJ) Announced
October 17, 2016
San Diego, CA -- (SBWIRE) -- 10/17/2016 -- St. Jude medical is under investigation over potential securities laws violations. The investigation was announced on behalf of investors in NYSE:STJ shares...
INVESTOR ALERT: Investigation of St. Jude Medical Inc. Announced by Law Offices of Howard G. Smith
October 14, 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of St. Jude Medical Inc. - STJ
October 11, 2016
Pomerantz LLP is investigating claims on behalf of investors of St. Jude Medical Inc. ("St. Jude" or the "Company") (NYSE: STJ) (ISIN: US7908491035). Investors are advised to contact Robert S....
St. Jude Medical Announces FDA Clearance and Launch of the New PressureWire X Guidewire Designed to Optimize PCI Procedures in Patients With Complex Anatomies
October 10, 2016
St. Jude Medical announces FDA clearance and launch of PressureWire X Guidewire. St. Jude Medical FFR technology has demonstrated improved patient outcomes and reduced costs associated with PCI.
St. Jude Medical Announces U.S. Launch and First Implant of New Deep Brain Stimulation System and Directional Lead for Patients Suffering from Movement Disorders
October 06, 2016
St. Jude Medical announces FDA approval of the Infinity DBS system with directional lead technology designed to help patients with Parkinson’s disease or essential tremor.
St. Jude Medical Announces European Full Market Release of EnSite Precision Cardiac Mapping System
October 05, 2016
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced a full market release of its EnSite Precision™ cardiac mapping system and new Sensor Enabled™ tools in Europe. The...
St. Jude Medical Announces FDA Approval of BurstDR Stimulation, a New Superior Spinal Cord Stimulation Option for Patients Suffering from Chronic Pain
October 04, 2016
BurstDR stimulation, exclusive to St. Jude Medical, aims to help patients find relief from their pain and suffering while also providing patients a better experience with their chronic pain therapy.